March 8, 2018 at 8:30 AM EST Update call November 16 - November 19, 2017 22ND ANNUAL SCIENTIFIC MEETING AND EDUCATION DAY OF THE SOCIETY FOR NEURO-ONCOLOGY November 14, 2017 VBL Therapeutics to Report Third Quarter 2017 Results August 14, 2017 at 8:30 AM EDT Q2 2017 VBL Therapeutics Earnings Conference Call Click here for webcast June 20, 2017 from 11:45 AM to 11:45 AM PDT 2017 BIO International Convention Presentation June 5, 2017 from 1:15 PM to 1:15 PM CEST ASCO 2017 Conference Presentation May 15, 2017 from 8:30 AM to 8:30 AM EDT Q1 2017 VBL Therapeutics Earnings Conference Call Click here for webcast May 12, 2017 from 12:00 PM to 12:00 PM EDT ASGCT 2017 Conference Presentation April 6, 2017 from 8:00 AM to 8:00 AM EDT Key Opinion Leader Breakfast: New Targets and Immuno-therapeutic Approaches in Oncology April 4, 2017 from 12:00 PM to 12:00 PM EDT VBL Therapeutics Presents Data on MOSPD2, a novel potential target in oncology First page « first Previous page ‹ previous … Page 4 Page 5 Page 6 Page 7 Current page 8 Page 9 Page 10 Page 11 Page 12 Next page next › Last page last »
November 16 - November 19, 2017 22ND ANNUAL SCIENTIFIC MEETING AND EDUCATION DAY OF THE SOCIETY FOR NEURO-ONCOLOGY
August 14, 2017 at 8:30 AM EDT Q2 2017 VBL Therapeutics Earnings Conference Call Click here for webcast
May 15, 2017 from 8:30 AM to 8:30 AM EDT Q1 2017 VBL Therapeutics Earnings Conference Call Click here for webcast
April 6, 2017 from 8:00 AM to 8:00 AM EDT Key Opinion Leader Breakfast: New Targets and Immuno-therapeutic Approaches in Oncology
April 4, 2017 from 12:00 PM to 12:00 PM EDT VBL Therapeutics Presents Data on MOSPD2, a novel potential target in oncology